Company Quick10K Filing
Levi Strauss
10-Q 2020-05-24 Filed 2020-07-07
10-Q 2020-02-23 Filed 2020-04-07
10-K 2019-11-24 Filed 2020-01-30
10-Q 2019-08-25 Filed 2019-10-08
8-K 2020-07-16 Officers, Regulation FD
8-K 2020-07-07 Earnings, Exit Costs, Officers, Exhibits
8-K 2020-04-14
8-K 2020-04-08
8-K 2020-04-02
8-K 2020-01-30
8-K 2020-01-28
8-K 2020-01-10
8-K 2019-10-08

Levi Strauss Financials

LEVI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Annual)

Revenue, G Profit, Net Income

Cash Flow ($BB Annual)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Beyond Meat (BYND) 10,014 33% -2,676.5 -3% 455 78 199 66 -12 -4 9,732
World Gold Trust (GLDW) 9,923 71.4 13% 1,051 0 0 0 139 139 9,923
Simply Good Foods (ATK) 9,838 48% 111.2 5% 1,125 295 492 235 53 88 9,787
Avantor (AVTR) 8,937 32% 34.8 -0% 9,763 7,408 3,036 965 -27 403 14,033
Tradeweb Markets (TW) 8,823 0% 52.9 1% 5,623 1,135 391 0 73 159 8,432
Haha Generation (HAHA) 8,365 1,375,364.1 34% 0 0 0 0 0 0 8,365
Fibria Celulose (FBR) 8,093 0% 38,693 24,043 0 0 0 0 4,853
Levi Strauss (LEVI) 7,570 54% 11.3 10% 4,139 2,671 5,786 3,097 397 681 7,712
Cheniere Energy Partners (CQH) 7,546 0% 21.1 40,650% 1 0 106 0 357 358 7,546
Scana (SCG) 6,991 0% -64.4 -3% 17,654 6,357 4 0 -589 -214 13,783
Great Plains Energy (GXP) 6,623 9.2 2% 12,448 3,898 0 0 201 986 9,090
DCT Industrial Trust (DCT) 6,436 0% 22.8 3% 4,083 2,007 434 0 125 360 8,200
Energen (EGN) 6,424 0% 9.0 7% 5,724 2,116 1,382 0 423 814 7,362
EQGP Holdings (EQGP) 6,194 0% 7.5 8% 9,268 4,213 867 0 701 829 6,188
Dynatrace (DT) 5,863 73% -34.1 -24% 1,933 1,047 252 183 -466 -182 6,221
Michael Kors (KORS) 5,778 61% 11.9 4% 8,393 5,981 5,570 3,374 337 672 8,010
Validus (VR) 5,456 -20% -37.2 -1% 15,499 9,928 2,881 -578 -193 -141 5,235
Envision Healthcare (EVHC) 5,406 0% -9.8 -13% 12,313 7,687 8,144 0 -1,555 -960 9,409
Foundation Medicine (FMI) 5,074 0% -42.1 -73% 193 202 201 0 -142 -119 5,019
Adaptive Biotechnologies (ADPT) 5,039 76% -180.1 -3% 917 331 48 37 -30 -28 4,961

Balance Sheet ($MM)2011-11-272012-11-252013-11-242014-11-302015-11-292016-11-272017-11-262018-11-252019-11-24
Cash2054064892983193766347130
Accounts Receivable6555014474824984794855340
Inventory6115196046016077167598840
PP&E5024591,2161,1773913944244610
Assets3,2803,1703,1272,9242,8842,9873,3553,5430
Accounts Payable2052262552352382702903510
Long-Term Debt1,8181,6691,5041,0921,0388388048500
Liabilities3,4293,2642,9142,6922,4842,3962,5252,5760
Stockholders' Equity-166-1071721533305106976600
Income Statement ($MM)2011-11-272012-11-252013-11-242014-11-302015-11-292016-11-272017-11-262018-11-252019-11-24
Revenue4,7624,6104,6824,7544,4944,5534,9045,5750
Cost of Revenue2,4692,4112,3312,4062,2262,2242,3412,5770
Gross Profit2,2922,1992,3502,3482,2692,3292,5632,9980
R&D0
SG&A1,9561,8651,8851,9061,8241,8662,0962,4610
Tax685547616157642150
Net Income1351412281042102912852850
Cash Flow ($MM)2011-11-272012-11-252013-11-242014-11-302015-11-292016-11-272017-11-262018-11-252019-11-24
Cash Operating25314112332183075264200
Cash Investing-141-75-93-72-81-68-124-1790
Cash Financing78-251-231-342-95-174-152-1480